Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 4/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.45 |
| ▸ | GAA | P10253 | 2/20 | 0.45 |
| ▸ | CDC25B | P30305 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | HPGD | P15428 | 3/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | GALR2 | O43603 | 1/20 | 0.43 |
| ▸ | MITF | O75030 | 1/20 | 0.43 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17707774 | 0.89 | ALDH1A1 (0.55) | TSHRMAPTMEN1MAPK1KMT2A | |
| SCHEMBL17707785 | 0.86 | TSHR (0.57) | TSHRMAPK1POLBALDH1A1HSD17B10 | |
| SCHEMBL27866294 | 0.85 | TSHR (0.58) | TSHRMAPK1POLBALDH1A1HSD17B10 | |
| SCHEMBL18285205 | 0.85 | TSHR (0.56) | TSHRMAPTMEN1MAPK1KMT2A | |
| SCHEMBL6656676 | 0.85 | MEN1 (0.68) | TSHRMAPTMEN1MAPK1KMT2A | |
| SCHEMBL17707787 | 0.85 | ALDH1A1 (0.56) | TSHRMAPTMEN1MAPK1KMT2A | |
| SCHEMBL22121398 | 0.84 | MEN1 (0.43) | TSHRMAPTMEN1MAPK1KMT2A | |
| SCHEMBL3789796 | 0.84 | ALDH1A1 (0.64) | TSHRMAPTMEN1MAPK1KMT2A | |
| SCHEMBL1979862 | 0.83 | ALDH1A1 (0.49) | TSHRMAPTMEN1KMT2APOLB | |
| SCHEMBL17707777 | 0.82 | TSHR (0.53) | TSHRMAPTMEN1MAPK1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4638455-A1 | HETEROCYCLIC GLP-1 AGONISTS | Gasherbrum Bio, Inc. (US) | 2025-10-29 | — | — | EP | disclosed |
| WO-2024138048-A1 | HETEROCYCLIC GLP-1 AGONISTS | GASHERBRUM BIO, INC. (US) | 2024-06-27 | — | — | WO | disclosed |
| CN-109071411-B | Method for producing nitrobenzene compound | 组合化学工业株式会社 | 2021-08-27 | — | — | CN | disclosed |
| EP-3456705-B1 | METHOD FOR PRODUCING NITROBENZENE COMPOUND | KUMIAI CHEMICAL INDUSTRY CO (JP) | 2020-12-16 | — | — | EP | disclosed |
| EP-3456705-A1 | METHOD FOR PRODUCING NITROBENZENE COMPOUND | Kumiai Chemical Industry Co., Ltd. (JP) | 2019-03-20 | — | — | EP | disclosed |
| EP-3015451-B1 | METHOD FOR PRODUCING NITROBENZENE COMPOUND | KUMIAI CHEMICAL INDUSTRY CO (JP) | 2018-01-17 | — | — | EP | disclosed |
| EP-3015451-A1 | METHOD FOR MANUFACTURING NITROBENZENE COMPOUND | Ihara Chemical Industry Co., Ltd. (JP) | 2016-05-04 | — | — | EP | disclosed |
| WO-2010135571-A1 | NOVEL PROTEIN KINASE MODULATORS | CYLENE PHARMACEUTICALS, INC. (US) | 2010-11-25 | — | — | WO | disclosed |
| US-20100298302-A1 | NOVEL PROTEIN KINASE MODULATORS | SENHWA BIOSCIENCES, INC. (TW) | 2010-11-25 | — | — | US | disclosed |
| US-20100298302-A1 | NOVEL PROTEIN KINASE MODULATORS | SENHWA BIOSCIENCES, INC. (TW) | 2010-11-25 | — | — | US | disclosed |
| WO-2010135571-A1 | NOVEL PROTEIN KINASE MODULATORS | CYLENE PHARMACEUTICALS, INC. (US) | 2010-11-25 | — | — | WO | disclosed |
| US-5543550-A | NITRATING ALKYL ESTER OF 3-FLUOROBENZOIC ACID DISSOLVED IN SOLVENT-FREE SULFURIC ACID, THEN ADDING WATER, SEPARATION, HYDROLYSIS, PRESSURIZED CATALYTIC HYDROGENATION OF THE NITRATED ACID | HOECHST AKTIENGESELLSCHAFT (DE) | 1996-08-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100298302-A1 | NOVEL PROTEIN KINASE MODULATORS | PIM2, PIM1, PIM3 | TSHR 3763/4885MAPT 2534/4885MEN1 4370/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.